Impact on the Quality of Life and Physiological Parameters in Patients with Diabetes Mellitus
Abstract
:Featured Application
Abstract
1. Introduction
2. Materials and Methods
2.1. Participants
2.2. Clinical Tests
2.2.1. Questionnaires
2.2.2. Peripheral Arterial Disease Assessment
2.2.3. Nerve Dysfunction Assessment
2.2.4. Other Physiological Assessments
2.3. Statistical Analysis
3. Results
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Federación Internacional de Diabetes. Atlas de la Diabetes de la FID 2019; 9a; Federación Internacional de Diabetes: Bruselas, Belgium, 2019; ISBN 9782930229874. [Google Scholar]
- Kato, A.; Fujimaki, Y.; Fujimori, S.; Isogawa, A.; Onishi, Y.; Suzuki, R.; Yamauchi, T.; Ueki, K.; Kadowaki, T.; Hashimoto, H. Psychological and behavioural patterns of stigma among patients with type 2 diabetes: A cross-sectional study. BMJ Open 2017, 7, e013425. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- de Gusmai, L.F.; de Novato, T.S.; de Nogueira, L.S. The influence of quality of life in treatment adherence of diabetic patients: A systematic review. Rev. Esc. Enferm. USP 2015, 49, 839–846. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saleh, F.; Mumu, S.J.; Ara, F.; Hafez, M.A.; Ali, L. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: A cross-sectional study. BMC Public Health 2014, 14, 1–8. [Google Scholar]
- Wukich, D.K.; Raspovic, K.M. Assessing Health-Related Quality of Life in Patients With Diabetic Foot Disease: Why Is It Important and How Can We Improve? The 2017 Roger E. Pecoraro Award Lecture. Diabetes Care 2018, 41, 391–397. [Google Scholar] [CrossRef] [Green Version]
- Zurita-Cruz, J.N.; Manuel-Apolinar, L.; Arellano-Flores, M.L.; Gutierrez-Gonzalez, A.; Najera-Ahumada, A.G.; Cisneros-González, N. Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: A cross-sectional study. Health Qual. Life Outcomes 2018, 16, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Xu, X.; Zhao, X.; Qian, D.; Dong, Q.; Gu, Z. Investigating Factors Associated with Depression of Type 2 Diabetic Retinopathy Patients in China. PLoS ONE 2015, 10, e0132616. [Google Scholar]
- Majeed, A.; Rehman, M.; Hussain, I.; Imran, I.; Saleem, M.U.; Saeed, H.; Hashmi, F.K.; Akbar, M.; Abrar, M.A.; Ramzan, B.; et al. The impact of treatment adherence on quality of life among type 2 diabetes mellitus patients—findings from a cross-sectional study. Patient Prefer. Adherence 2021, 15, 475–481. [Google Scholar] [CrossRef]
- Navarro-Flores, E.; Cauli, O. Quality of Life in Individuals with Diabetic Foot Syndrome. Endocr. Metab. Immune Disord.Drug Targets 2020, 20, 1365–1372. [Google Scholar] [CrossRef]
- Alrub, A.A.; Hyassat, D.; Khader, Y.S.; Bani-Mustafa, R.; Younes, N.; Ajlouni, K. Factors associated with health-related quality of life among Jordanian patients with diabetic foot ulcer. J. Diabetes Res. 2019, 2019, 4706720. [Google Scholar] [CrossRef] [Green Version]
- Al Ayed, M.; Ababneh, M.; Alwin Robert, A.; Al Misfer, N.; Cruz, M.; Austria, H.C.; Al Dawish, M. Factors Associated With Health-Related Quality of Life in Patients With Diabetic Foot Ulcer: A Cross-Sectional Study From Saudi Arabia. Cureus 2020, 12, e8658. [Google Scholar] [CrossRef] [PubMed]
- Bourdel-Marchasson, I.; Druet, C.; Helmer, C.; Eschwege, E.; Lecomte, P.; Le-Goff, M.; Sinclair, A.J.; Fagot-Campagna, A. Correlates of health-related quality of life in French people with type 2 diabetes. Diabetes Res. Clin. Pract. 2013, 101, 226–235. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitu and Its Complications: Report of a WHO Consultation. Part 1, Diagnosis and Classification of Diabetes Mellitus; World Health Organization: Geneva, Switzerland, 1999. [Google Scholar]
- Alonso, J.; Prieto, L.; Antó, M. La versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): Un instrumento para la medida de los resultados clínicos. Med. Clin. 1995, 104, 771–776. [Google Scholar]
- Ware, J.E.; Sherbourne, C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992, 30, 473–483. [Google Scholar] [CrossRef] [PubMed]
- Ahn, J.; Del Core, M.A.; Wukich, D.K.; Liu, G.T.; Lalli, T.; VanPelt, M.D.; La Fontaine, J.; Lavery, L.A.; Raspovic, K.M. Scoring Mental Health Quality of Life With the SF-36 in Patients With and Without Diabetes Foot Complications. Int. J. Low. Extrem. Wounds 2018, 17, 30–35. [Google Scholar] [CrossRef]
- Altinok, A.; Marakoğlu, K.; Kargın, N. Evaluation of quality of life and depression levels in individuals with Type 2 diabetes. J. Fam. Med. Prim. Care 2016, 5, 302. [Google Scholar]
- Van Netten, J.J.; Bus, S.A.; Apelqvist, J.; Lipsky, B.A.; Hinchliffe, R.J.; Game, F.; Rayman, G.; Schaper, N.C. IWGDF Definitions and Criteria Definitions and criteria for diabetic foot disease. Diabetes Metab. Res. Rev. 2020, 36, e3268. [Google Scholar] [PubMed] [Green Version]
- Hinchliffe, R.J.; Brownrigg, J.R.W.; Apelqvist, J.; Boyko, E.J.; Fitridge, R.; Mills, J.L.; Reekers, J.; Shearman, C.P.; Zierler, R.E.; Schaper, N.C. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diabetes. Metab. Res. Rev. 2016, 32, 37–44. [Google Scholar] [CrossRef] [Green Version]
- Aboyans, V.; Sevestre, M.A.; Désormais, I.; Lacroix, P.; Fowkes, G.; Criqui, M.H. Epidemiology of lower extremity artery disease. Press. Medicale 2018, 47, 38–46. [Google Scholar] [CrossRef]
- Viadé Julià, J.; Royo Serrando, J. Pie Diabético: Guía Para la Práctica Clínica; 2a; Panamerinana: Madrid, Spain, 2013; ISBN 9788491104780. [Google Scholar]
- Domínguez-Olmedo, J.M.; Munuera-Martínez, P.V.; Sáez-Díaz, A.; Palomo-Toucedo, I.C.; Vázquez-Bautista, C.; Reina-Bueno, M. Impact of peripheral artery disease on the quality of life of patients with diabetes mellitus. Foot 2019, 41, 1–5. [Google Scholar] [CrossRef]
- Herranz, L. Índice Tobillo Brazo Para La Evaluación De La Enfermedad Arterial Periférica. Av Diabetol 2005, 21, 224–226. [Google Scholar]
- International Diabetes Federation. Clinical Practice Recommendation on the Diabetic Foot: A Guide for Health Care Professionals; International Diabetes Federation: Brussels, Belgium, 2017. [Google Scholar]
- Menz, H.B. Two feet, or one person? Problems associated with statistical analysis of paired data in foot and ankle medicine. Foot 2004, 14, 2–5. [Google Scholar] [CrossRef]
- Laucis, N.C.; Hays, R.D.; Bhattacharyya, T. Scoring the SF-36 in Orthopaedics: A Brief Guide. J. Bone Jt. Surg.-Am. Vol. 2015, 97, 1628–1634. [Google Scholar] [CrossRef] [Green Version]
- Jiang, Y.; Ran, X.; Jia, L.; Yang, C.; Wang, P.; Ma, J.; Chen, B.; Yu, Y.; Feng, B.; Chen, L.; et al. Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China. Int. J. Low. Extrem. Wounds 2015, 14, 19–27. [Google Scholar] [CrossRef]
- Al-Rubeaan, K.; Al Derwish, M.; Ouizi, S.; Youssef, A.M.; Subhani, S.N.; Ibrahim, H.M.; Alamri, B.N. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS ONE 2015, 10, 1–17. [Google Scholar] [CrossRef]
- DiMatteo, M.R.; Lepper, H.S.; Croghan, T.W. Depression is a risk factor for noncompliance with medical treatment meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 2000, 160, 2101–2107. [Google Scholar] [CrossRef]
- Rathmann, W.; Kuß, O.; Anderson, D.; Busch, S.; Hahn, M.; Engelhard, J.; Zou, M.; Kostev, K. Increased depression symptom score in newly diagnosed type 2 diabetes patients. Psychiatry Res. 2018, 261, 259–263. [Google Scholar] [CrossRef]
- Dobrică, E.C.; Găman, M.A.; Cozma, M.A.; Bratu, O.G.; Stoian, A.P.; Diaconu, C.C. Polypharmacy in type 2 diabetes mellitus: Insights from an internal medicine department. Medicina 2019, 55, 436. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Găman, M.A.; Cozma, M.A.; Dobrică, E.C.; Bacalbașa, N.; Bratu, O.G.; Diaconu, C.C. Dyslipidemia: A trigger for coronary heart disease in Romanian patients with diabetes. Metabolites 2020, 10, 195. [Google Scholar] [CrossRef] [PubMed]
- Aurrecoechea, E.; Llorca Díaz, J.; Diez Lizuain, M.L.; McGwin, G.; Calvo-Alen, J. Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: Data from GENIRA. Rheumatol. Int. 2017, 37, 479–485. [Google Scholar] [CrossRef] [PubMed]
- Sepúlveda, E.; Poínhos, R.; Constante, M.; Pais-Ribeiro, J.; Freitas, P.; Carvalho, D. Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital. Diabetes, Metab. Syndr. Obes. Targets Ther. 2015, 8, 219. [Google Scholar] [CrossRef] [Green Version]
- Del Core, M.A.; Ahn, J.; Wukich, D.K.; Liu, G.T.; Lalli, T.; VanPelt, M.D.; Raspovic, K.M. Gender Differences on SF-36 Patient-Reported Outcomes of Diabetic Foot Disease. Int. J. Low. Extrem. Wounds 2018, 17, 87–93. [Google Scholar] [CrossRef]
- Venkataraman, K.; Wee, H.L.; Leow, M.K.S.; Tai, E.S.; Lee, J.; Lim, S.C.; Tavintharan, S.; Wong, T.Y.; Ma, S.; Heng, D.; et al. Associations between complications and health-related quality of life in individuals with diabetes. Clin. Endocrinol. 2013, 78, 865–873. [Google Scholar] [CrossRef]
- Yeboah, K.; Puplampu, P.; Ainuson, J.; Akpalu, J.; Gyan, B.; Amoah, A.G.B. Peripheral artery disease and exertional leg symptoms in diabetes patients in Ghana. BMC Cardiovasc. Disord. 2016, 16, 1–9. [Google Scholar] [CrossRef] [Green Version]
- Kacerovsky-Bielesz, G.; Lienhardt, S.; Hagenhofer, M.; Kacerovsky, M.; Forster, E.; Roth, R.; Roden, M. Sex-related psychological effects on metabolic control in type 2 diabetes mellitus. Diabetologia 2009, 52, 781–788. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Currie, C.J.; Poole, C.D.; Woehl, A.; Morgan, C.L.; Cawley, S.; Rousculp, M.D.; Covington, M.T.; Peters, J.R. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 2006, 49, 2272–2280. [Google Scholar] [CrossRef] [PubMed]
- García-Morales, E.; Lázaro-Martínez, J.L.; Martínez-Hernández, D.; Aragón-Sánchez, J.; Beneit-Montesinos, J.V.; González-Jurado, M.A. Impact of Diabetic Foot Related Complications on the Health Related Quality of Life (HRQol) of Patients—A Regional Study in Spain. Int. J. Low. Extrem. Wounds 2011, 10, 6–11. [Google Scholar] [CrossRef] [PubMed]
- Ribu, L.; Hanestad, B.R.; Moum, T.; Birkeland, K.; Rustoen, T. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual. Life Res. 2007, 16, 179–189. [Google Scholar] [CrossRef] [PubMed]
- Ribu, L.; Birkeland, K.; Hanestad, B.R.; Moum, T.; Rustoen, T. A longitudinal study of patients with diabetes and foot ulcers and their health-related quality of life: Wound healing and quality-of-life changes. J. Diabetes Complicat. 2008, 22, 400–407. [Google Scholar] [CrossRef] [PubMed]
- Raspovic, K.M.; Hobizal, K.B.; Rosario, B.L.; Wukich, D.K. Midfoot Charcot Neuroarthropathy in Patients With Diabetes. Foot Ankle Spec. 2015, 8, 255–259. [Google Scholar] [CrossRef] [Green Version]
- Yekta, Z.; Pourali, R.; Ghasemi-rad, M. Comparison of demographic and clinical characteristics influencing health-related quality of life in patients with diabetic foot ulcers and those without foot ulcers. Diabetes, Metab. Syndr. Obes. Targets Ther. 2011, 4, 393. [Google Scholar] [CrossRef] [Green Version]
- Peek, M.E. Gender Differences in Diabetes-related Lower Extremity Amputations. Clin. Orthop. Relat. Res. 2011, 469, 1951–1955. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Variables N = Valid Sample | Men | Women | Significance * |
---|---|---|---|
Calcification presence on RX. Right foot. N = 46 | n = 18 58.1% | n = 3 20% | p = 0.016 |
Calcification presence on RX. Left foot. N = 46 | n = 19 61.3% | n = 3 20% | p = 0.009 |
Sensory neuropathy. Right foot. Semmes–Weinstein monofilament tests. N = 50 | n = 6 17.1% | n = 2 13.3% | p = 0.345 |
Sensory neuropathy. Left foot. Semmes–Weinstein monofilament tests. N = 50 | n = 8 22.9% | n = 2 13.3% | p = 0.243 |
Pain sensitivity disorder. Right foot. (Neuropen) N = 46 | n = 5 16.1% | n = 2 13.3% | p = 0.589 |
Pain sensitivity disorder. Left foot. (Neuropen) N = 46 | n = 5 16.1% | n = 2 13.3% | p = 0.589 |
Sudomotor dysfunction. Right foot. (Neuropad) N = 42 | n = 11 39.3% | n = 2 14.3% | p = 0.246 |
Sudomotor dysfunction. Left foot. (Neuropad) N = 42 | n = 11 39.3% | n = 2 14.3% | p = 0.246 |
Altered vibratory sensitivity. Right foot. (Rydel-Seiffer graded tuning fork) N = 42 | n = 13 41.9% | n = 3 20% | p = 0.128 |
Altered vibratory sensitivity. Left foot. (Rydel-Seiffer graded tuning fork) N = 42 | n = 14 45.2% | n = 3 20% | p = 0.090 |
More than 2 °C in skin temperature difference. (Digital Feet Thermo Scale system) N = 44 | n = 1 3.3% | n = 0 0% | p = 0.682 |
Oxygen saturation level less than 95%. (Distal pulse oximeter) N = 47 | n = 4 12.5% | n = 4 26.8% | p = 0.196 |
Wounds | Neuropathy | Fontaine (Between II and IV) | ||
---|---|---|---|---|
Women (15) | N (positive) * | 3 (15) | 3 (15) | 4 (15) |
Percentage | 20.0% | 20.0% | 26.7 | |
Men (35) | N (positive) * | 16 (35) | 15 (30) | 4 (33) |
Percentage | 45.7% | 42.9% | 11.4% |
Variables | Women Mean (SD) | Men Mean (SD) | Significance (p) |
---|---|---|---|
Total health | 54.2 ± (17.5) | 63.77 ± (20.21) | 0.073 |
Physical function | 66.33 ± (21.25) | 65.14 ± (26.91) | 0.966 |
Physical role | 60 ± (44.12) | 60 ± (39.85) | 0.938 |
Bodily pain | 54.67 ± (26.72) | 59.2 ± (30.75) | 0.595 |
General health | 52 ± (13.47) | 62 ± (20.41) | 0.094 |
Vitality | 57.33 ± (22.67) | 58.71 ± (27.02) | 0.164 |
Social function | 65.47 ± (28.57) | 75.91 ± (27.28) | 0.200 |
Emotional role | 37.67 ± (4.55) | 69.43 ± (42.32) | 0.028 |
Mental health | 56.27 ± (17.60) | 72.83 ± (21.32) | 0.003 |
Health change | 41.67 ± (15.43) | 54.46 ± (18.66) | 0.028 |
Wound | Neuropathy | Peripheral Arteriopathy | |||||||
---|---|---|---|---|---|---|---|---|---|
Yes | No | Yes | No | Yes | No | ||||
T | M | 66.13 | 61.79 | M | 58.67 | 67.80 | M | 43.00 | 67.10 |
W | 49.33 | 55.42 | W | 39.00 | 58.00 | W | 40.00 | 59.36 | |
p | 0.465 | p | 0.246 | p | 0.136 | ||||
PF | M | 65.00 | 65.26 | M | 58.67 | 67.67 | M | 31.25 | 69.31 |
W | 56.67 | 68.75 | W | 46.67 | 71.25 | W | 43.75 | 74.55 | |
p | 0.733 | p | 0.094 | p | 0.672 | ||||
PR | M | 60.94 | 59.21 | M | 55.00 | 66.67 | M | 50.00 | 62.07 |
W | 41.67 | 64.58 | W | 58.33 | 72.92 | W | 18.75 | 75.00 | |
p | 0.729 | p | 0.091 | p | 0.408 | ||||
BP | M | 61.63 | 57.16 | M | 54.60 | 61.07 | M | 36.50 | 62.62 |
W | 42.00 | 57.83 | W | 45.33 | 57.00 | W | 47.00 | 57.45 | |
p | 0.968 | p | 0.402 | p | 0.348 | ||||
GH | M | 67.50 | 57.37 | M | 59.33 | 64.00 | M | 37.50 | 65.52 |
W | 48.33 | 52.92 | W | 48.33 | 52.92 | W | 42.50 | 55.45 | |
p | 0.121 | p | 0.852 | p | 0.048 | ||||
V | M | 63.44 | 54.74 | M | 50.67 | 63.67 | M | 26.25 | 63.10 |
W | 66.67 | 55.00 | W | 53.33 | 58.33 | W | 66.25 | 54.09 | |
p | 0.316 | p | 0.231 | p | 0.030 | ||||
SF | M | 76.88 | 75.11 | M | 70.07 | 82.80 | M | 45.25 | 82.03 |
W | 49.00 | 69.59 | W | 49.67 | 69.42 | W | 56.00 | 68.91 | |
p | 0.839 | p | 0.376 | p | 0.126 | ||||
ER | M | 77.00 | 63.05 | M | 59.93 | 79.93 | M | 66.50 | 72.34 |
W | 44.33 | 36.00 | W | 51.00 | 44.33 | W | 16.50 | 45.36 | |
p | 0.149 | p | 0.343 | p | 0.290 | ||||
MH | M | 70.75 | 74.58 | M | 72.60 | 75.20 | M | 54.00 | 76.86 |
W | 62.67 | 54.67 | W | 57.33 | 56.00 | W | 47.00 | 59.64 | |
p | 0.826 | p | 0.403 | p | 0.012 | ||||
HC | M | 56.25 | 52.95 | M | 52.07 | 51.67 | M | 43.75 | 53.66 |
W | 33.33 | 43.75 | W | 33.33 | 43.75 | W | 25.00 | 47.73 | |
p | 0.469 | p | 0.471 | p | 0.410 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Reina-Bueno, M.; Palomo-Toucedo, I.C.; Medina-Núñez, M.Á.; Munuera-Martínez, P.V.; Castro-Méndez, A.; Vázquez-Bautista, M.d.C. Impact on the Quality of Life and Physiological Parameters in Patients with Diabetes Mellitus. Appl. Sci. 2021, 11, 6829. https://doi.org/10.3390/app11156829
Reina-Bueno M, Palomo-Toucedo IC, Medina-Núñez MÁ, Munuera-Martínez PV, Castro-Méndez A, Vázquez-Bautista MdC. Impact on the Quality of Life and Physiological Parameters in Patients with Diabetes Mellitus. Applied Sciences. 2021; 11(15):6829. https://doi.org/10.3390/app11156829
Chicago/Turabian StyleReina-Bueno, María, Inmaculada C. Palomo-Toucedo, Manuel Ángel Medina-Núñez, Pedro V. Munuera-Martínez, Aurora Castro-Méndez, and María del Carmen Vázquez-Bautista. 2021. "Impact on the Quality of Life and Physiological Parameters in Patients with Diabetes Mellitus" Applied Sciences 11, no. 15: 6829. https://doi.org/10.3390/app11156829
APA StyleReina-Bueno, M., Palomo-Toucedo, I. C., Medina-Núñez, M. Á., Munuera-Martínez, P. V., Castro-Méndez, A., & Vázquez-Bautista, M. d. C. (2021). Impact on the Quality of Life and Physiological Parameters in Patients with Diabetes Mellitus. Applied Sciences, 11(15), 6829. https://doi.org/10.3390/app11156829